Events

Medical Technology presentation series

Leveraging change and embracing innovation

MedTech market shifts and competitive advantages

In today’s value-based care environment, product development and go-to-market strategy comes with greater regulatory uncertainty and a rapidly transforming customer base.

Deloitte Consulting LLP is pleased to present a three-part presentation series, hosted by LifeScience Alley, designed to provide strategic insights on the opportunities and risks Medical Technology companies are exposed to as they navigate the changing health care industry and market disrupters.

Innovating in mHealth: The opportunities and pitfalls entering the emerging market

The opportunities created through the adoption of mHealth have resulted in non-Medical Technology companies entering the space with solutions that play a role beyond preventive care and wellness but also in diagnosis, medical decision making, and treatment protocols.

Despite widespread applicability of mHealth solutions, data security, patient privacy, and uncertainty regarding the effectiveness of mobile devices is raising the levels of regulatory activity. These dynamics are considered a barrier in the U.S. even as collaborations across multiple stakeholders are becoming more common.

Join Deloitte Consulting LLP and LifeScience Alley for a discussion on the challenges and opportunities mHealth technologies present to the traditional Medical Technology market. The session will address:

  • What are the pitfalls to be aware of in the R&D process such as regulatory and privacy hurdles?
  • What are the challenges and the implications for manufacturers partnering with provider systems?
  • What are the opportunities for manufacturers and providers in the emerging mHealth market?

Additional Presentations:

Event details:

Date:

July 23, 2015

Location:

DoubleTree by Hilton Minneapolis North

Registration:

More information and registration

Monetizing health information: Opportunities, risks and realities

The evolution of health delivery is driving substantial disruption and new capabilities in health informatics, analytics and predictive modeling. With these new capabilities comes an accelerated focus to monetize patient information via improved outcomes and reduced costs. While Medical Technology companies face risks from innovators and non-traditional competitors, there may be opportunity to monetize analytics, drive efficient care delivery, improve outcomes and enhance the patient journey.

Join Deloitte Consulting LLP and LifeScience Alley to explore key areas companies should consider prior to embarking on a data analytics pathway, such as addressing information ownership and privacy, measuring and capturing value, and monetizing dimensions of health information. Also learn more about practical steps companies can take to assess opportunities and risks. This session will explore the following questions:

  • How can a life science company assess opportunities to monetize analytics and improve patient outcomes?
  • How can a company appropriately mitigate risks arising from market disruption?
  • Who really owns a patient’s health information?

Additional Presentations:

Event details:

Date:

September 22, 2015

Location:

DoubleTree by Hilton Minneapolis North

Registration:

More information and registration

Delivering medical technology innovation in a value-based care environment

In the United States, payers and providers have begun the transition to value-based care with increasing emphasis on improving health outcomes per dollar spent, widespread reporting of quality, outcomes, and cost, and convergence among industry players to drive integration across the continuum of care. The “customer” for Medical Technology companies has shifted from the individual physician to insurers, hospital administrators and consumers, while new entities are emerging to influence clinical pathways and protocols. These different stakeholders are increasingly weighing price against performance in their decisions to purchase medical technologies and evaluating product performance in the context of demonstrable quality metrics, reduced readmissions, or patient satisfaction scores.

Join Deloitte Consulting LLP and Life Sciences Alley for a discussion on how Medical Technology innovators can define a compelling value-proposition for these different stakeholders. This panel will address the following questions:

  • What does a successful value proposition look like, and how will winning strategies evolve in the next 3-5 years?
  • How do new market demands impact the innovation process to get products to market and maximize their value? What are the critical “winning capabilities” to be developed across the enterprise?
  • How should Medical Device companies approach different stakeholders?
  • What smart next steps should Medical Device companies take?

Event details:

Date:

October, 29, 2015

Location:

DoubleTree by Hilton Minneapolis North

Registration:

More information and registration